✕
Login
Register
Back to News
Heron Therapeutics Affirms FY2026 Sales Guidance of $173.000M-$183.000M vs $174.733M Est
Benzinga Newsdesk
www.benzinga.com
Negative 48.3%
Neg 48.3%
Neu 0%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment